We are live on ! Find out more
ACM

Ascendant Capital Management Portfolio holdings

AUM $75.7M
1-Year Est. Return 12.68%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+12.68%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$33.5M
AUM Growth
+$9.51M
Cap. Flow
+$8.78M
Cap. Flow %
26.24%
Top 10 Hldgs %
44.38%
Holding
48
New
22
Increased
5
Reduced
9
Closed
6

Top Buys

Rank Stock Value
1
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$2.39M
2
ANGL icon
VanEck Fallen Angel High Yield Bond ETF
ANGL
+$1.48M
3
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$1.32M
4
LLY icon
Eli Lilly
LLY
+$1.06M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.01M

Top Sells

Rank Stock Value
1
FLOT icon
iShares Floating Rate Bond ETF
FLOT
+$2.97M
2
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$1.74M
3
ASO icon
Academy Sports + Outdoors
ASO
+$717K
4
UNH icon
UnitedHealth
UNH
+$530K
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$518K

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Healthcare 14.41%
3 Industrials 10.73%
4 Consumer Discretionary 8.61%
5 Communication Services 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMD icon
26
Advanced Micro Devices
AMD
$789B
$648K 1.94%
10,000
– –
UTHR icon
27
United Therapeutics
UTHR
$23.1B
$556K 1.66%
+2,000
New +$505K
CI icon
28
Cigna
CI
$74.6B
$497K 1.49%
1,500
– –
TTD icon
29
Trade Desk
TTD
$6.49B
$448K 1.34%
10,000
– –
CAH icon
30
Cardinal Health
CAH
$55.4B
$423K 1.26%
+5,500
New +$418K
BAH icon
31
Booz Allen Hamilton
BAH
$9.15B
$418K 1.25%
+4,000
New +$416K
MSFT icon
32
Microsoft
MSFT
$3.71T
$408K 1.22%
1,700
-1,300
-43% -$312K
MCD icon
33
McDonald's
MCD
$195B
$395K 1.18%
1,500
-200
-12% -$52.8K
VRTX icon
34
Vertex Pharmaceuticals
VRTX
$126B
$375K 1.12%
1,300
-1,700
-57% -$518K
AGNC icon
35
AGNC Investment
AGNC
$12.9B
$362K 1.08%
+35,000
New +$320K
REGN icon
36
Regeneron Pharmaceuticals
REGN
$80.8B
$361K 1.08%
+500
New +$369K
MRNA icon
37
Moderna
MRNA
$23.6B
$359K 1.07%
+2,000
New +$327K
NBIX icon
38
Neurocrine Biosciences
NBIX
$16.6B
$358K 1.07%
+3,000
New +$351K
SPY icon
39
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$349K 1.04%
+500
New +$192K
SPY icon
40
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$330K 0.99%
+2,000
New +$769K
JBL icon
41
Jabil
JBL
$35.8B
$307K 0.92%
+4,500
New +$297K
ENPH icon
42
Enphase Energy
ENPH
$5.53B
$265K 0.79%
+1,000
New +$291K
ASO icon
43
Academy Sports + Outdoors
ASO
$2.98B
– –
-17,000
Closed -$717K
BAB icon
44
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
– –
-20,000
Closed -$513K
FLOT icon
45
iShares Floating Rate Bond ETF
FLOT
$10.3B
– –
-59,000
Closed -$2.97M
SRLN icon
46
State Street Blackstone Senior Loan ETF
SRLN
$5.34B
– –
-12,000
Closed -$490K
TBF icon
47
ProShares Short 20+ Year Treasury ETF
TBF
$104M
– –
-10,000
Closed -$223K
TLT icon
48
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
– –
-17,000
Closed -$1.74M
1
2

Similar funds

UPC
Utah Peaks Capital Park City, Utah $75.4M AUM
CFA
Compass Financial Advisors Fort Wayne, Indiana $78.9M AUM 0.9% 1-Year Est. Return
HLCM
Hickory Lane Capital Management New York $81.7M AUM 4.68% 1-Year Est. Return
SAM
Stone Asset Management Austin, Texas $62.6M AUM 8.13% 1-Year Est. Return
RA
Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return
ACM
Acrisure Capital Management Austin, Texas $98.8M AUM
F
Fithian New York $47.9M AUM
CCM
CTC Capital Management Chicago, Illinois $47.8M AUM 5.18% 1-Year Est. Return

Ascendant Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Ascendant Capital Management held 48 positions worth $33.5M, up 40% from $23.9M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Ascendant Capital Management deployed $8.78M of net new capital in Q4 2022, opening 22 new positions and adding to 5 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 18,000 shares worth $2.45M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was UnitedHealth, an estimated $530K trimmed.

  • Ascendant Capital Management's largest Q4 2022 buy was State Street Health Care Select Sector SPDR ETF: 18,000 shares worth $2.45M.
  • Ascendant Capital Management added most to Invesco Senior Loan ETF in Q4 2022, an estimated $850K increase.
  • Ascendant Capital Management's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $530K.
  • Ascendant Capital Management fully exited iShares Floating Rate Bond ETF in Q4 2022, selling an estimated $2.97M.
  • Ascendant Capital Management's ten largest holdings make up 44% of its $33.5M portfolio in Q4 2022.
  • Ascendant Capital Management opened 22 new positions and closed 6 in Q4 2022.
  • Ascendant Capital Management's portfolio value rose 40% quarter-over-quarter to $33.5M.

Based on Ascendant Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.